Evaluation of the Qvella FAST System and the FAST-PBC cartridge for rapid species identification and antimicrobial resistance testing directly from positive blood cultures

Issa Sy,Nina Bühler,Sören L. Becker,Philipp Jung
DOI: https://doi.org/10.1128/jcm.00569-23
2023-09-29
Journal of Clinical Microbiology
Abstract:ABSTRACT Blood culture diagnostics require rapid and accurate identification (ID) of pathogens and antimicrobial susceptibility testing (AST). Standard procedures, involving conventional cultivation on agar plates, may take up to 48 hours or more until AST completion. Recent approaches aim to shorten the processing time of positive blood cultures (PBC). The FAST System is a new technology, capable of purifying and concentrating bacterial/fungal pathogens from positive blood culture media and producing a bacterial suspension called “liquid colony” (LC), which can be further used in downstream analyses (e.g., ID and AST). Here, we evaluated the performance of the FAST System LC generated from PBC in comparison to our routine workflow including ID by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using Sepsityper, AST by automatized MicroScan WalkAway plus and directly inoculated disk diffusion (DD), and MICRONAUT-AM for yeast/fungi. A total of 261 samples were analyzed, of which 86.6% (226/261) were eligible for the comparative ID and AST analyses. In comparison to the reference technique (culture-grown colonies), ID concordance of the FAST System LC and Sepsityper was 150/154 (97.4%) and 123/154 (79.9%), respectively, for Gram positive; 67/70 (95.7%) and 64/70 (91.4%), respectively, for Gram negative. For AST, categorical agreement (CA) of the FAST System LC in comparison to the routine workflow for Gram-positive bacteria was 96.1% and 98.7% for MicroScan and DD, respectively. Similar results were obtained for Gram-negative bacteria with 96.6% and 97.5% of CA for MicroScan and DD, respectively. Taken together, the FAST System LC allowed the laboratory to significantly reduce the time to obtain correct ID and AST (automated MicroScan) results 1 day earlier and represents a promising tool to expedite the processing of PBC.
microbiology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to quickly and accurately identify pathogens (Identification, ID) from positive blood cultures (PBC) and conduct antimicrobial susceptibility testing (AST) in clinical microbiology. Traditional culture methods usually require 24 hours for pathogen identification and 48 hours to complete the final AST results, which leads to treatment delays and may have an adverse impact on patients, especially in cases of severe infections such as sepsis. Therefore, it is of great significance to develop faster methods to identify pathogens from PBC and conduct subsequent resistance testing. To meet this challenge, researchers evaluated a new technology - the "Liquid Colony" (LC) generated by the Qvella FAST system and compared it with the conventional workflow. Specifically, the researchers focused on the following points: 1. **Speed and accuracy of pathogen identification**: Evaluate the performance of LC generated by the FAST system in pathogen identification. Compared with the standard Sepsityper method based on Matrix - Assisted Laser Desorption/Ionization Time - of - Flight Mass Spectrometry (MALDI - TOF MS), can it identify pathogens more quickly and accurately? 2. **Speed and accuracy of antimicrobial susceptibility testing**: Evaluate the performance of LC generated by the FAST system in antimicrobial susceptibility testing. Compared with the conventional automated MicroScan WalkAway system and the direct inoculation disk diffusion method (Disk Diffusion, DD), can it complete AST more quickly and accurately? 3. **Time savings in the overall process**: Evaluate whether the use of LC generated by the FAST system can significantly shorten the time from positive blood culture to obtaining correct identification and AST results. Through these evaluations, researchers hope to verify the potential of the FAST system as a fast and accurate tool for handling PBC in clinical laboratories.